Testing effectiveness (Phase 2)Ended earlyNCT01746173What this trial is testingCHOEP + High Dose Therapy + Auto SCT for T-Cell LymphomaWho this might be right forT-cell Non-Hodgkin Lymphoma Dana-Farber Cancer Institute 5
Large-scale testing (Phase 3)Active Not RecruitingNCT02390869What this trial is testingRituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL PatientsWho this might be right forLymphoma, Follicular Fondazione Italiana Linfomi - ETS 128
Testing effectiveness (Phase 2)Ended earlyNCT00632827What this trial is testingTreatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)Who this might be right forPeripheral T-Cell Lymphoma University of California, San Francisco 21
Not applicableStudy completedNCT00956475What this trial is testingQuality of Life in Younger Leukemia and Lymphoma SurvivorsWho this might be right forAnxiety DisorderCancer SurvivorFatigue+7 more Case Comprehensive Cancer Center 48
Testing effectiveness (Phase 2)Ended earlyNCT02763254What this trial is testingCellular Immunotherapy for Viral Induced Cancer - EBV Positive LymphomasWho this might be right forHodgkin LymphomaLymphoma, Large B-Cell, DiffusePost-transplant Lymphoproliferative Disorder Cell Medica Ltd 1
Testing effectiveness (Phase 2)Ended earlyNCT01805037What this trial is testingBrentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+114 more Northwestern University 20
Testing effectiveness (Phase 2)Study completedNCT01849783What this trial is testingAutologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple MyelomaWho this might be right forExtramedullary PlasmacytomaIsolated Plasmacytoma of BoneLight Chain Deposition Disease+4 more Margarida Magalhaes-Silverman 41
Testing effectiveness (Phase 2)UnknownNCT00328237What this trial is testingTreatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood TransplantationWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myeloid Leukemia+2 more Colorado Blood Cancer Institute 20
Testing effectiveness (Phase 2)Study completedNCT00948922What this trial is testingMelphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple MyelomaWho this might be right forMultiple Myeloma H. Lee Moffitt Cancer Center and Research Institute 124
Testing effectiveness (Phase 2)Study completedNCT00574496What this trial is testingCombination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center 25
Not applicableStudy completedNCT00993694What this trial is testingMethemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With DapsoneWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+6 more Vanderbilt University 41
Large-scale testing (Phase 3)Study completedNCT00928018What this trial is testingTacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With LymphomaWho this might be right forNon-hodgkin LymphomaHodgkin Lymphoma Dana-Farber Cancer Institute 139
Testing effectiveness (Phase 2)Looking for participantsNCT04491370What this trial is testingAutologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin LymphomaWho this might be right forB-cell LymphomaBurkitt LymphomaDiffuse Large B Cell Lymphoma+6 more New York Medical College 20
Testing effectiveness (Phase 2)Study completedNCT00467961What this trial is testingStem Cell Transplantation for Patients With Cancers of the BloodWho this might be right forCML (Chronic Myelogenous Leukemia)CLL (Chronic Lymphocytic Leukemia)AML (Acute Myelogenous Leukemia)+2 more National Heart, Lung, and Blood Institute (NHLBI) 61
Large-scale testing (Phase 3)Study completedNCT00004165What this trial is testingMelphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm Northwestern University
Early research (Phase 1)Study completedNCT00244946What this trial is testingCombination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Barbara Ann Karmanos Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT02896582What this trial is testingEfficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven MaintenanceWho this might be right forMantle Cell Lymphoma The Lymphoma Academic Research Organisation 86
Not applicableStudy completedNCT00920842What this trial is testingStudy of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell TransplantWho this might be right forCardiovascular ComplicationsLeukemiaLong-term Effects Secondary to Cancer Therapy in Children+1 more Fred Hutchinson Cancer Center 244
Early research (Phase 1)Study completedNCT00110071What this trial is testingIodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for Relapsed or Refractory Non-Hodgkin's LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+12 more Fred Hutchinson Cancer Center 38
Testing effectiveness (Phase 2)Study completedNCT00800839What this trial is testingBusulfan and Fludarabine Followed by Post-transplant CyclophosphamideWho this might be right forHematologic DiseasesLeukemiaLymphoma+1 more M.D. Anderson Cancer Center 56